Tango Therapeutics, Inc. (TNGX)
19.64
-0.40
(-2.02%)
USD |
NASDAQ |
May 27, 16:00
19.64
0.00 (0.00%)
After-Hours: 16:34
Tango Therapeutics Cash from Investing (Quarterly) : 9.635M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Kodiak Sciences, Inc. | -0.942M |
| Revolution Medicines, Inc. | 172.62M |
| Erasca, Inc. | -243.83M |
| Hims & Hers Health, Inc. | -15.45M |
| Gilead Sciences, Inc. | 1.77B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -44.36M |
| Cash from Financing (Quarterly) | 79.85M |
| Free Cash Flow | -142.55M |
| Free Cash Flow Per Share (Quarterly) | -0.309 |
| Free Cash Flow to Equity (Quarterly) | -43.58M |
| Free Cash Flow to Firm (Quarterly) | -44.36M |
| Free Cash Flow Yield | -5.85% |